Quantum Biopharma Ltd. (QNTM) stock
QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52−0.07 (-4.40%)
Close on Nov 18, 2026Market cap $5.91MP/E –Yield –
Quantum Biopharma operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quantum Biopharma's operating income for the twelve months ending Jun 30, 2026 was -$12.31M. For fiscal 2025 it was -$15.30M. The highest annual figure on record is -$15.30M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.30M | – |
| FY2024 | Dec 31, 2024 | -$16.14M | – |
| FY2023 | Dec 31, 2023 | -$23.79M | – |
| FY2022 | Dec 31, 2022 | -$27.43M | – |
| FY2021 | Dec 31, 2021 | -$33.74M | – |
| FY2020 | Dec 31, 2020 | -$30.69M | – |
| FY2019 | Dec 31, 2019 | -$22.48M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.29M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.97M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.68M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.85M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.24M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.46M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.26M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.80M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.31M | – |
See a number that looks wrong?